Skip to content

CELU

Celularity Inc

NASDAQ · Healthcare · Biotechnology · US

$0.81
−1.02%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
0.57x
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
-0.74x
Price / sales
1.41x
Price / cash flow
-2.94x

Enterprise value

Enterprise value
$61.7M
EV / sales
3.30x
EV / EBITDA
-1.70x
EV / EBIT
-1.25x
Market cap
$26.2M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026